Product Code: IRTNTR31886
About this market
Technavio's clinical reference laboratory services market analysis considers sales clinical chemistry, human and tumor genetics, medical biology and cytology, and esoteric tests. Our analysis also considers the sales of clinical reference laboratory services in Asia, Europe, North America, and ROW. In 2018, the clinical chemistry segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as shortage of skilled workforce will play a significant role in the clinical chemistry segment to maintain its market position. Also, our global clinical reference laboratory services market report looks at factors such as the increasing prevalence of the chronic and infectious disease, increased outsourcing of testing services to reference laboratories, and increasing access to online test services. However, uncertainties in stringent regulations and privacy concerns related to IT in laboratory infrastructure may hamper the growth of the clinical reference laboratory services industry over the forecast period.
Overview
Increasing outsourcing of testing services to reference laboratories
Hospitals are facing the pressure of maintaining a low cost of laboratory operations. This has increased the outsourcing of laboratory operations to reference laboratories. Outsourcing helps lower the costs involved in hiring sophisticated and costly instruments and skilled expertise. It increases the efficiency of healthcare practitioners to focus on offering quality care to the patients. This will lead to the expansion of the global clinical reference laboratory services market at a CAGR of over 6% during the forecast period.
Increasing integration of EMRs with LIS
Electronic medical record (EMR) systems have gained significant applications in the healthcare sector due to their benefits, such as real-time patient data collection and easy accessibility to them for future reference. Hospitals and clinics have started integrating EMR systems with laboratory information systems (LISs) to help end-users improve the process of online laboratory test ordering and access to report results. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global clinical reference laboratory services market during the forecast period 2019-2023, view our report.
Competitive Landscape
With the presence of several major players, the global clinical reference laboratory services market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical reference laboratory services manufacturers, that include Genomic Health Inc., Laboratory Corp. of America Holdings, OPKO Health Inc., Quest Diagnostics Inc., SYNLAB Bondco Plc.
Also, the clinical reference laboratory services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
TABLE OF CONTENTS
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY SERVICE
- Market segmentation by service
PART 07: MARKET SEGMENTATION BY END-USER
- Market segmentation by end-user
PART 08: MARKET SEGMENTATION BY APPLICATION
- Market segmentation by application
- Comparison by application
- Clinical chemistry - Market size and forecast 2018-2023
- Human and tumor genetics - Market size and forecast 2018-2023
- Medical microbiology and cytology - Market size and forecast 2018-2023
- Other esoteric tests - Market size and forecast 2018-2023
- Market opportunity by application
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Increasing partnerships between reference laboratories and risk management service providers
- Increasing integration of EMRs with LIS
- Increasing adoption of inorganic growth strategies
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Genomic Health Inc.
- Laboratory Corp. of America Holdings
- OPKO Health Inc.
- Quest Diagnostics Inc.
- SYNLAB Bondco Plc
PART 15: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
LIST OF EXHIBITS:
- Exhibit 01: Service overview
- Exhibit 02: Global healthcare market
- Exhibit 03: Segments of global healthcare market
- Exhibit 04: Market characteristics
- Exhibit 05: Market segments
- Exhibit 06: Market definition - Inclusions and exclusions checklist
- Exhibit 07: Market size 2018
- Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions)
- Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
- Exhibit 10: Five forces analysis 2018
- Exhibit 11: Five forces analysis 2023
- Exhibit 12: Bargaining power of buyers
- Exhibit 13: Bargaining power of suppliers
- Exhibit 14: Threat of new entrants
- Exhibit 15: Threat of substitutes
- Exhibit 16: Threat of rivalry
- Exhibit 17: Market condition - Five forces 2018
- Exhibit 18: Global clinical reference laboratory services market: Segmentation by service 2018 (%)
- Exhibit 19: Global clinical reference laboratory services market: Segmentation by end-user 2018 (%)
- Exhibit 20: Application - Market share 2018-2023 (%)
- Exhibit 21: Comparison by application
- Exhibit 22: Clinical chemistry - Market size and forecast 2018-2023 ($ billions)
- Exhibit 23: Clinical chemistry - Year-over-year growth 2019-2023 (%)
- Exhibit 24: Human and tumor genetics - Market size and forecast 2018-2023 ($ billions)
- Exhibit 25: Human and tumor genetics - Year-over-year growth 2019-2023 (%)
- Exhibit 26: Medical microbiology and cytology - Market size and forecast 2018-2023 ($ billions)
- Exhibit 27: Medical microbiology and cytology - Year-over-year growth 2019-2023 (%)
- Exhibit 28: Other esoteric tests - Market size and forecast 2018-2023 ($ billions)
- Exhibit 29: Other esoteric tests - Year-over-year growth 2019-2023 (%)
- Exhibit 30: Market opportunity by application
- Exhibit 31: Customer landscape
- Exhibit 32: Market share by geography 2018-2023 (%)
- Exhibit 33: Geographic comparison
- Exhibit 34: North America - Market size and forecast 2018-2023 ($ billions)
- Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
- Exhibit 36: Europe - Market size and forecast 2018-2023 ($ billions)
- Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
- Exhibit 38: Asia - Market size and forecast 2018-2023 ($ billions)
- Exhibit 39: Asia - Year-over-year growth 2019-2023 (%)
- Exhibit 40: ROW - Market size and forecast 2018-2023 ($ billions)
- Exhibit 41: ROW - Year-over-year growth 2019-2023 (%)
- Exhibit 42: Key leading countries
- Exhibit 43: Market opportunity
- Exhibit 44: Vendor landscape
- Exhibit 45: Landscape disruption
- Exhibit 46: Vendors covered
- Exhibit 47: Vendor classification
- Exhibit 48: Market positioning of vendors
- Exhibit 49: Genomic Health Inc. - Vendor overview
- Exhibit 50: Genomic Health Inc. - Business segments
- Exhibit 51: Genomic Health Inc. - Organizational developments
- Exhibit 52: Genomic Health Inc. - Geographic focus
- Exhibit 53: Genomic Health Inc. - Key offerings
- Exhibit 54: Laboratory Corp. of America Holdings - Vendor overview
- Exhibit 55: Laboratory Corp. of America Holdings - Business segments
- Exhibit 56: Laboratory Corp. of America Holdings - Organizational developments
- Exhibit 57: Laboratory Corp. of America Holdings - Geographic focus
- Exhibit 58: Laboratory Corp. of America Holdings - Segment focus
- Exhibit 59: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 60: OPKO Health Inc. - Vendor overview
- Exhibit 61: OPKO Health Inc. - Business segments
- Exhibit 62: OPKO Health Inc. - Organizational developments
- Exhibit 63: OPKO Health Inc. - Geographic focus
- Exhibit 64: OPKO Health Inc. - Segment focus
- Exhibit 65: OPKO Health Inc. - Key offerings
- Exhibit 66: Quest Diagnostics Inc. - Vendor overview
- Exhibit 67: Quest Diagnostics Inc. - Business segments
- Exhibit 68: Quest Diagnostics Inc. - Organizational developments
- Exhibit 69: Quest Diagnostics Inc. - Segment focus
- Exhibit 70: Quest Diagnostics Inc. - Key offerings
- Exhibit 71: SYNLAB Bondco Plc - Vendor overview
- Exhibit 72: SYNLAB Bondco Plc - Business segments
- Exhibit 73: SYNLAB Bondco Plc - Organizational developments
- Exhibit 74: SYNLAB Bondco Plc - Geographic focus
- Exhibit 75: SYNLAB Bondco Plc - Key offerings
- Exhibit 76: Validation techniques employed for market sizing
- Exhibit 77: Definition of market positioning of vendors
